FDA reviews when Bayer revealed drug risks
263858
In a move that could lead to a criminal investigation, the government is checking its records to determine if drug maker Bayer AG was forthcoming about safety concerns with
415435
An internal survey of Food and Drug Administration scientists conducted by the Health and Human Services Office of the Inspector General revealed safety concerns about the FDAâs approval process and monitoring of marketed drugs, according to a press
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
15642
NEW YORK, December 21  - The US Food and Drug Administration (FDA) warned today against the long-term usage of another arthritis drug, naproxen, after studies revealed increased risks of cardiovascular events.
16125
The Food and Drug Administration yesterday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
422908
- Bayer HealthCare, a U.S.-based unit of Bayer AG , stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer, after an independent data monitoring committee concluded that the study would not meet the main goal of improved overall survival.
329407
Responding to a spate of deaths in clinical trials, the Food and Drug Administration yesterday issued its most severe warning possible for drugs widely used to treat anemia in kidney disease patients and cancer patients undergoing chemotherapy.
589260
Consumer Reports' effort to rate drugs offers a lesson to pharmaceutical companies.
343910
A veteran scientist at the Food and Drug Administration said yesterday he will present new, unpublished findings about heart risk associated with a number of pain drugs at a meeting to assess whether they are safe enough for patients.
448573
A document released by the FDA outlines its concerns with GPC's lead drug.
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.
167999
U.S. drug safety regulators are  coming under fire for their response to years of suspicions,  confirmed last week, that arthritis drug Vioxx increased the  risks of heart attacks and strokes.
612661
U.S. drug safety regulators are coming under fire for their response to years of suspicions, confirmed last week, that arthritis drug Vioxx increased the risks of heart attacks and strokes.
6332
Drug maker Bayer was slow to report the risks of its cholesterol-lowering drug Baycol and to remove it from the market in 2001, according to an forthcoming report in the Journal of the American Medical Association.
134671
Bayer HealthCare, a U.S.-based unit  of Bayer AG , said on Monday it had stopped a  late-stage trial of Nexavar in patients with non-small cell  lung cancer, after an independent data monitoring committee  said it would not meet the main goal of improved overall  survival.
455038
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol drug Vytorin after a study showed it was no better than a generic in preventing the build-up of fatty plaque.
303984
At least five medications now sold to consumers pose such risks that their sale should be limited or stopped, said a government drug reviewer who raised safety questions earlier about the arthritis drug Vioxx.